Skip to content
Ancell Corporation
Search
  • Shopping Cart
  • Contact Us / US Orders
  • International Orders
  • Terms
Ancell Corporation
Search
  • Home
  • Shopping Cart
  • Contact Us /US Orders
  • International Orders
  • Terms
  • Procedures
  • Material Safety Data Sheet (MSDS)
  • Hot Topics
  • Home
  • Products
    • New Products
    • Anti-Human Antibodies
    • Anti-Mouse Antibody
    • Cytokine related
    • Immune Checkpoint
    • Isotype Controls
    • Progenitor/Stem Cell
    • Recombinant Proteins
    • Second-Step Reagents
    • TNF Superfamily
  • Information
    • Hot Topics
    • US Orders / Price lists
    • International Orders
    • Procedures
    • MSDS

A Review of Antibody Drug Conjugate (ADC) treatments for Lymphoma

By Paul Everson / August 21, 2023

“Antibody-drug conjugates for lymphoma patients: preclinical and clinical evidences” Marelia Barreca, et al. Explor Target Antitumor Ther. 2022; 3(6): 763–794. Published online 2022 Dec 26. doi: 10.37349/etat.2022.00112 PMID: 36654819

Relevant Ancell Research Products

anti-human CD269(BCMA) mAb

human CD269(BCMA) Recombinant Protein

anti-human CD22 mAb

anti-human CD79b

anti-CD19 mAb

← Previous Post
Next Post →

All prices are in U.S. dollars. International prices may vary.

Copyright © 2025 Ancell Corporation. All rights reserved.